Healthcare & Life Sciences
NovalGen
United Kingdomwww.novalgen.com/
NovalGen is a startup based in the United Kingdom, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About NovalGen
NovalGen is a company headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
NovalGen is a clinical-stage biotechnology company developing multi-specific biologic immunotherapies. The company is advancing an AutoRegulation platform to create self-regulating antibody and T-cell engager therapies for oncology, autoimmune, haematological, and metabolic disorders.
Explore NovalGen's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.